Back to BCAX
Royalty Pharma Sub-Manager, LLC → BCAX
Royalty Pharma Sub-Manager, LLC BCAX Position History
Bicara Therapeutics Inc. • Healthcare
Quarters held
3
Latest value
$60.6M
Q2 2026
Peak value
$60.6M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $45.9M |
| Q1 2026 | $46.7M |
| Q2 2026 | $60.6M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $60.6M | 2.39M | — | — |
| Q1 2026 | $46.7M | 2.39M | — | — |
| Q4 2025 | $45.9M | 1.26M | — | — |
Other funds holding BCAX
$93.9M
$63.1M
$60.8M
$60.8M
$54.4M
$53.4M
$50.1M